Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574774 | 0.75 | CA12 (0.37) | ALDH1A1CASP7TDP1 | |
| SCHEMBL10621031 | 0.70 | CA12 (0.31) | — | |
| SCHEMBL896338 | 0.64 | CA12 (0.36) | ALDH1A1CASP1CASP7HSD17B10TDP1 | |
| SCHEMBL16875692 | 0.63 | CA12 (0.38) | ALDH1A1TDP1 | |
| SCHEMBL6249309 | 0.63 | KDM4E (0.33) | ALDH1A1 | |
| SCHEMBL6578197 | 0.63 | CA12 (0.36) | ALDH1A1CASP1CASP7HSD17B10TDP1 | |
| SCHEMBL10445492 | 0.61 | ALDH1A1 (0.53) | ALDH1A1CASP1CASP7HSD17B10TDP1 | |
| SCHEMBL4432972 | 0.60 | ALDH1A1 (0.40) | ALDH1A1CASP1CASP7HSD17B10TDP1 | |
| SCHEMBL17774563 | 0.60 | TDP1 (0.71) | ALDH1A1CASP1CASP7HSD17B10TDP1 | |
| SCHEMBL530145 | 0.60 | CA12 (0.52) | ALDH1A1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140162906-A1 | Pesticide Biomarker | NAGY JON OWEN (US) | 2014-06-12 | — | — | US | disclosed |
| US-20110166043-A1 | BIOMARKER DETECTION-2 | ATERIS TECHNOLOGIES, LLC | 2011-07-07 | — | — | US | disclosed |
| US-20100041077-A1 | PESTICIDE BIOMARKER | ATERIS TECHNOLOGIES, LLC | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166043-A1 | BIOMARKER DETECTION-2 | CPB2, NAALAD2, PRSS2 | ALDH1A1 1052/4885CASP1 2081/4885CASP7 3167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.